In this video, I discuss my latest experiences on the road, including the vehicles I've been driving and a showcase of automotive highlights. Join me for insights into the automotive industry and ...
Ford tops the list with three of the most unreliable vehicles according to Consumer Reports, but some other brands aren't far ...
Sanofi SA (NASDAQ:SNY) on Wednesday released topline data from a phase 2 study evaluating the efficacy and safety of AlphaMedix (212Pb-DOTAMTATE). The patients had unresectable or metastatic ...
AlphaMedix TM (212 Pb-DOTAMTATE) achieved all primary efficacy endpoints in phase 2 study, demonstrating clinically meaningful benefits in patients with gastroenteropancreatic neuroendocrine tumors ...
ANAVEX3-71-SZ-001 achieved its primary endpoint demonstrating safety and tolerability in adults with schizophrenia Encouraging trends observed in biomarkers support continued development NEW YORK, Oct ...
(RTTNews) - Neurocrine Biosciences, Inc. (NBIX) announced the presentation of new data from the Phase 2 SAVITRI study, which showed statistically significant and clinically meaningful improvement in ...
Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
SAN DIEGO, Sept. 16, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it will present new data from the Phase 2 SAVITRI study of osavampator in adults with major ...
Rapport Therapeutics, Inc.'s RAP-219 delivered impressive Phase 2a results in drug-resistant focal onset seizures, driving Rapport Therapeutics' stock up over 135% and boosting investor optimism. The ...
DUBLIN, Sept. 7, 2025 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced detailed positive results from the Vibrance-1 phase 2 study evaluating alixorexton in patients with narcolepsy type 1 ...
Share on Pinterest To lower diabetes risk, simply following a Mediterranean diet may not be enough, new research suggests. Image credit: Helen Rushbrook/Stocksy About one in every nine adults around ...